HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Who is Dr. Houman Hemmati, potentially CBER’s next leader?

Where the rumored frontrunner stands on key issues like vaccines and public health policy.

By PharmaVoice · Apr 20, 2026 · via PharmaVoice
Who is Dr. Houman Hemmati, potentially CBER’s next leader?

Image: PharmaVoice

Tags
peopleformat:headlineheadlinePharmaVoice
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
Teva launches new online schizophrenia community project
PeopleFiercePharma ↗
Just two months after the FDA accepted for review Teva’s long-acting version of a decades-old schizophrenia dr…
Apr 18, 2026
Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
PeopleFiercePharma ↗
Omnicom Health has stamped its mark on the recently acquired FCB Health New York, rebranding the ad agency as …
Apr 18, 2026
Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
PeopleFiercePharma ↗
For Astellas’ chief manufacturing officer, Rao Mantri, Ph.D., production is not just about a reliable supply o…
Apr 18, 2026